Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2016

Estrogen activation of microglia underlies the sexually dimorphic
differences in Nf1 optic glioma-induced retinal pathology
Joseph A. Toonen
Washington University School of Medicine in St. Louis

Anne C. Solga
Washington University School of Medicine in St. Louis

Yu Ma
Washington University School of Medicine in St. Louis

David H. Gutmann
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Toonen, Joseph A.; Solga, Anne C.; Ma, Yu; and Gutmann, David H., ,"Estrogen activation of microglia
underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology." The Journal of
Experimental Medicine. 214,1. 17-25. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5436

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Br ief Definitive Repor t

Estrogen activation of microglia underlies the sexually
dimorphic differences in Nf1 optic glioma–induced
retinal pathology
Joseph A. Toonen, Anne C. Solga,Yu Ma, and David H. Gutmann

C hildren with neurofibromatosis type 1 (NF1) develop low-grade brain tumors throughout the optic pathway. Nearly 50% of
children with optic pathway gliomas (OPGs) experience visual impairment, and few regain their vision after chemotherapy.
Recent studies have revealed that girls with optic nerve gliomas are five times more likely to lose vision and require treatment
than boys. To determine the mechanism underlying this sexually dimorphic difference in clinical outcome, we leveraged Nf1
optic glioma (Nf1-OPG) mice. We demonstrate that female Nf1-OPG mice exhibit greater retinal ganglion cell (RGC) loss and
only females have retinal nerve fiber layer (RNFL) thinning, despite mice of both sexes harboring tumors of identical volumes
and proliferation. Female gonadal sex hormones are responsible for this sexual dimorphism, as ovariectomy, but not castration,
of Nf1-OPG mice normalizes RGC survival and RNFL thickness. In addition, female Nf1-OPG mice have threefold more microglia than their male counterparts, and minocycline inhibition of microglia corrects the retinal pathology. Moreover, pharmacologic inhibition of microglial estrogen receptor-β (ERβ) function corrects the retinal abnormalities in female Nf1-OPG mice.
Collectively, these studies establish that female gonadal sex hormones underlie the sexual dimorphic differences in Nf1 optic
glioma–induced retinal dysfunction by operating at the level of tumor-associated microglial activation.

Introduction
Neurofibromatosis type 1 (NF1) is a monogenic cancer
predisposition syndrome that results from germline mutations in the NF1 tumor suppressor gene and predisposes
affected individuals to develop benign and malignant tumors. One of the significant clinical challenges in managing children and adults with NF1 is the extreme clinical
heterogeneity of the disease. In this regard, 15–20% of
children with NF1 develop low-grade astrocytomas along
the optic pathway, termed optic pathway gliomas (OPGs;
Listernick et al., 1994). These tumors, characterized by low
proliferative indices and infiltration of microglia, lead to
visual impairment in 30–50% of children with NF1-OPGs.
Unfortunately, this decline in visual acuity is frequently
irreversible after successful chemotherapy (Kalin-Hajdu
et al., 2014). In addition, it is not clear which child with
an NF1-OPG will experience visual decline and require
treatment, necessitating that all young children with NF1
undergo annual ophthalmological evaluations to identify
those with reduced visual acuity using age-appropriate visual tests (Listernick et al., 2007). Moreover, these assessments require that preverbal children cooperate and fully
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engage during the examination, which is often challenging for children with NF1 who harbor comorbid attention
deficits (Hyman et al., 2005).
To identify potential risk factors for OPG-induced
visual decline, we recently found that girls with NF1 are
more likely to lose vision and require treatment than boys
(Diggs-Andrews et al., 2014b). Importantly, when segmented
by tumor location within the optic pathway, girls with optic
nerve gliomas were 5–10 times more likely to experience visual decline than their male counterparts (Diggs-Andrews et
al., 2014a; Fisher et al., 2014). Because boys and girls with
NF1 develop OPGs at relatively similar frequencies, these
findings indicate that a sexually dimorphic effect may underlie OPG-induced vision loss.
In this study, we leveraged an Nf1 genetically engineered mouse strain that similarly exhibits sexually dimorphic
differences in optic glioma–induced visual acuity impairment
to define the molecular and cellular basis for these effects
(Diggs-Andrews et al., 2014b). We demonstrate, for the first
time, that female gonadal sex hormones are responsible for
increased retinal ganglion cell (RGC) loss and retinal nerve
fiber layer (RNFL) thinning secondary to murine optic glioma, which reflects estrogen receptor activation of tumor-associated microglia. Together, these findings establish that
© 2017 Toonen et al. This article is distributed under the terms of an Attribution–Noncommercial–Share
Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org
/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 4.0 International license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
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female gonadal sex hormones act as microglial activators in
the pathogenesis of NF1-OPG visual decline.
Results and discussion
RGC death and RNFL loss are sexually
dimorphic in Nf1-OPG mice
To define the molecular and cellular basis underlying the
observed sexually dimorphic visual decline in children with
NF1-OPG, we used a credentialed Nf1-OPG genetically engineered mouse strain (Bajenaru et al., 2003), in which optic
nerve and chiasmal gliomas form by 3 mo of age, and mice
exhibit decreased visual acuity in a sexually dimorphic manner by 6 mo of age (Diggs-Andrews et al., 2014b). A 56%
18

reduction in RGC numbers (% Brn3a+ cells) was observed
in female Nf1-OPG mice relative to controls (Nf1flox/flox mice
[FF]), with only minor changes in their male counterparts
(Fig. 1 A). The reduction in RGC number was caused by
increased apoptosis, as indicated by a 10-fold increase in the
percentage of cleaved caspase-3+ cells (Fig. 1 B). The selective death of RGCs (Fig. 1 C) reflects a predominance of
Nf1 protein (neurofibromin) expression in RGCs within the
retina (Fig. 1 D). Consistent with RGC death resulting from
axonal injury, increased phospho-neurofilament heavy chain
(pNF-H) immunostaining, a marker of axonal injury (ParrillaReverter et al., 2009), was observed in the optic nerves of
female Nf1-OPG mice (Fig. 1 E).
Estrogen increases microglia-mediated retinal damage | Toonen et al.

Downloaded from jem.rupress.org on August 29, 2017

Figure 1. Retinal dysfunction is sexually dimorphic in Nf1-OPG mice. (A) The percentage of Brn3a+ RGCs was decreased in female Nf1-OPG mice
(mean, 56.13 ± 13.11% SD; n = 7 mice) compared with FF controls (103.6 ± 8.6%; n = 7 mice), and to a lesser degree in their male counterparts (FF males,
100 ± 10.91%; n = 7 mice; Nf1-OPG males, 79.01 ± 11.6%; n = 7 mice). (B) Cleaved caspase-3+ cells were increased in female Nf1-OPG mice (15.52 ± 4.52%;
n = 6 mice) compared with FF controls (1.45 ± 1.09%; n = 6 mice), but were less elevated in male Nf1-OPG mice (0.822 ± 1.29%; n = 8 mice) relative to FF
controls (6.451 ± 3.72%; n = 6 mice). (C) Double-labeled Brn3a+ (red) and TUNEL+ cells (green) were detected in female Nf1-OPG mice. (D) Neurofibromin
(green) was primarily expressed in Brn3a+ (red) RGCs in WT mice. (E) pNF-H immunostaining was detected in the optic nerves of female Nf1-OPG mice, but
not Nf1-OPG males or controls. (F) IPL-GCL layer thickness showed no differences in males (FF, 54.41 ± 6.3 µm; n = 6 mice; OPG, 51.23 ± 6.67 µm; n = 6
mice), whereas thinning was found in Nf1-OPG females (39.54 ± 3.55 µm; n = 7 mice) compared with controls (FF, 60.1 ± 5.96 µm; n = 6 mice). (G) SMI-32
staining (RNFL thickness) revealed thinning in female Nf1-OPG retinae (4.82 ± 0.64 µm; n = 6 mice) relative to controls (10.14 ± 1.99 µm; n = 6 mice). No
differences were seen in males (FF, 10.37 ± 1.5 µm; n = 6 mice; OPG, 10.22 ± 3.46 µm; n = 6 mice). (H) Decreased SMI-32 staining was observed in female
Nf1-OPG retinal flatmounts (left) and by immunoblotting (right). Data in A, B, F, and G were analyzed using a one-way ANOVA (Kruskal-Wallis test) with a
Dunn’s multiple comparison post-test. Similar results were obtained in a second independent experiment containing six mice per group. Bars, 100 µm. *, P <
0.05; **, P < 0.01; ***, P < 0.001.

In children with NF1, optical coherence tomography
(OCT) is often used to monitor visual dysfunction secondary
to OPG (Fisher et al., 2012). OCT measures the thickness of
the RNFL (composed of RGC axons) and the inner plexiform layer/ganglion cell layer (IPL-GCL; Avery et al., 2011;
Gu et al., 2014). Similar to the sexually dimorphic RGC
effects, IPL-GCL and RNFL thicknesses were reduced by
34.2% (Fig. 1 F) and 52% (Fig. 1 G) in female Nf1-OPG
mice, respectively, compared with controls. No significant
differences were found between male Nf1-OPG mice and
controls, as further demonstrated using retinal flat-mount
preparations (SMI-32 immunostaining) and Western blotting
(Fig. 1 H). Together, these observations establish that female
Nf1-OPG mice exhibit greater tumor-induced axonal injury,
leading to RGC loss and RNFL/IPL-GCL thinning.

JEM Vol. 214, No. 1

Optic glioma–associated microglia activation underlie
axonal damage and retinal dysfunction in Nf1-OPG mice
Microglia comprise 30–50% of the cells in human NF1-associated and sporadic low-grade gliomas (Simmons et al., 2011).
Although their murine counterparts have slightly lower percentages of microglia (10–15% Iba1+ cells), these Nf1 mouse
optic glioma–associated monocytes (Daginakatte and Gutmann, 2007) and their secreted chemokines (Ccl5; Solga et
al., 2015) are critical for tumor maintenance. Based on these
findings, we focused on microglia as potential cellular mediators of the observed sexually dimorphic effects.
First, we observed that female Nf1-OPG mice harbored
2.8-fold more optic glioma–associated microglia compared
with their male counterparts (Fig. 3 A). Second, microglia
numbers were also elevated in female, but not male, Nf1+/−
optic nerves relative to their WT counterparts, even in
the absence of an optic glioma (Fig. 3 B). Third, there was
greater microglial activation (Daginakatte et al., 2008) in
female Nf1-OPG mice, as indicated by a 3.2-fold increase
in phospho-JNK+ cells, relative to their male counterparts.
However, Ccl5 expression did not differ between male and
female Nf1-OPG mice, suggesting that this chemokine
functions to support tumor growth in both males and females (unpublished data).
Because the proliferation and volumes of male and female murine optic gliomas were equivalent, we postulated
that the relative increase in microglia and microglial activation
might underlie the sexually dimorphic differences in optic
glioma–induced retinal dysfunction. As such, previous studies
have demonstrated that microglia can increase neuronal cell
death and axonal injury in other experimental nervous system
diseases (Neher et al., 2011; Schneider et al., 2015). Additionally, gonadal sex hormones, such as estrogen, have been previously implicated in brain microglia function (Tapia-Gonzalez
et al., 2008; Saijo et al., 2011). To determine whether gonad
ectomy changes microglia content, we examined the percentage of Iba1+ cells after gonadectomy. Although castration had
no effect on microglial content, there was an approximately
twofold decrease in the percentage of Iba1+ cells after OVX,
reducing microglia numbers to WT levels (Fig. 3 C). Additionally, the percentage of amoeboid-shaped (activated) microglia was reduced from 70 to 32% after OVX (Fig. 3 D).
To determine whether inhibition of microglia function
could attenuate retinal dysfunction and axonal damage, female Nf1-OPG mice were treated with minocycline, a commonly used microglial pharmacologic inhibitor (Tikka et
al., 2001). After treatment, there was a 1.7-fold decrease in
the percentage of Iba1+ cells (Fig. 3 E), decreased pNF-H
immunostaining (Fig. 3 E), and a 3.9-fold decrease in the
19
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Female gonadal sex hormones underlie the sexually
dimorphic differences in Nf1-OPG–induced axonal damage
and retinal dysfunction
Using the AOS strategy (Arnold, 2014), we first analyzed gonadal steroid hormones (estradiol, testosterone) as responsible
etiologies. Although gonadal sex hormones are usually considered to function during or after puberty, there is an abundance of experimental data supporting critical roles for these
hormones in brain neurons during fetal and early perinatal
life in several vertebrate species (Bondesson et al., 2015). 4-vinylcyclohexene diepoxide (VCD) was initially used to chemically ablate ovarian function (Kappeler and Hoyer, 2012),
which reduced RGC death (%TUNEL+ cells) by 2.97-fold
(Fig. 2 A) and increased RGC numbers (%Brn3a+ cells)
from 50 to 73% of WT levels (Fig. 1 A). Because VCD can
have off-target effects, we performed surgical ovariectomies
(OVX) of female Nf1-OPG mice, castration (Cast) of male
Nf1-OPG mice, and respective sham surgeries at 6 wk of age.
After male gonadectomy, serum testosterone levels decreased
by 8.3-fold (Fig. 2 B); however, there was no change in
RGC death (%TUNEL+ cells and %Brn3a+ cells) or RNFL
thinning (Fig. 2 C). These results demonstrate that male gonadal sex hormones do not provide a neuroprotective effect
for RGC survival in the setting of optic glioma. In contrast,
OVX resulted in a 7.2-fold decrease in serum 17-β estradiol
levels (Fig. 2 B) and a 4.3-fold reduction in the percentage of
TUNEL+ cells, increasing the percentage of Brn3a+ cells from
∼50 to ∼77% and RNFL thickness from ∼46 to ∼100% of
WT levels, respectively (Fig. 2 D).
Because girls and boys with NF1 are equally likely to
develop an optic glioma (Diggs-Andrews et al., 2014b), we
examined the optic gliomas in male and female Nf1-OPG
mice. No differences were observed between male and female Nf1-OPG mice with respect to tumor penetrance, optic
nerve volumes, proliferation, or astrocyte number (Fig. 2 E);
however, OVX significantly affected glioma maintenance.
Castrated males showed no differences in optic nerve volumes or proliferation (Fig. 2 F) or pNF-H immunostaining
(Fig. 2 F), but OVX Nf1-OPG females exhibited a 42% de-

crease in optic nerve volume, a 70% decrease in proliferation,
and reduced optic nerve pNF-H staining (Fig. 2 G). Collectively, these findings establish that gonadal sex hormones are
critical for optic glioma growth, axonal damage, and retinal
pathology in female Nf1-OPG mice.
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Figure 2. Depletion of female gonadal sex hormones rescues tumor growth and RGC death in Nf1-OPG females. (A) VCD treatment decreased
TUNEL+ cells in the RGC layer (Vehicle, 14.8 ± 2.7%; VCD, 4.9 ± 2.9; n = 6 mice) and increased the percentage of Brn3a+ RGCs in FMC mice (Vehicle, 49.3
± 10.8%; VCD, 73.1 ± 7.5; n = 7 mice/group). (B) Serum testosterone levels decreased after castration (Cast) of male Nf1-OPG mice (Sham, 1.19 ±0.14 ng/
ml; Cast, 0.14 ± 0.05 ng/ml; n = 5 mice/group). Serum 17-β estradiol levels decreased after OVX of female Nf1-OPG mice (Sham, 9.33 ± 2.1 pmol/ml; OVX,
1.29 ± 0.88 pmol/ml; n = 7 mice/group). (C) Castration did not change retinal apoptosis (%TUNEL+ cells; Sham, 6.53 ± 1.83; Cast, 6.25 ± 2.16; n = 7 mice),
RGC loss (%Brn3a+ cells; Sham, 83.78 ± 6.7; Cast, 86.21 ± 8.1; n = 7 mice/group), or RNFL thickness (SMI-32 staining; Sham, 10.14 ± 2.35 µm; Cast, 10.77
± 2.2 µm; n = 7 mice/group). (D) OVX reduced RGC death (%TUNEL+ cells; Sham, 13.19 ± 4.0; OVX, 2.98 ± 1.2; n = 7 mice/group), RGC loss (%Brn3a; Sham,
49.56 ± 13.9; OVX, 77.42 ± 11.7; n = 7 mice/group), and RNFL thinning (SMI-32 staining; Sham, 5.51 ± 1.6 µm; OVX, 12.2 ± 1.97 µm; n = 7 mice/group).
(E) No differences in optic nerve volumes (Male, 0.087 ± 0.003 mm3; Female, 0.095 ± 0.011 mm3; n = 17 mice/group), %Ki67+ cells (Male, 3.95 ± 2.81%;
Female 3.76 ± 0.81%; n = 9 mice/group), or percentage of S100β+ cells (Male, 65.35 ± 5.01%; Female, 59.81 ± 5.1%; n = 5 mice/group) were found in the
optic nerves of male compared with female Nf1-OPG mice. (F) Optic nerve volume measurements (top; Sham, 0.084 ± 0.02 mm3; Cast, 0.092 ± 0.02 mm3;
n = 6 mice/group), %Ki67+ cells (middle; Sham, 3.08 ± 1.1%; Cast, 3.19 ± 2.08%; n = 6 mice/group), and pNF-H staining (bottom) within the optic nerve were
20
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percentage of TUNEL+ cells (Fig. 3 F). In addition, the percentage of Brn3a+ cells increased from ∼40 to ∼70%, and
RNFL thickness increased from ∼38 to ∼97% of WT levels,
respectively (Fig. 3 F), thus establishing an essential role for
microglia in mediating glioma maintenance (Daginakatte and
Gutmann, 2007), as well as axonal damage, RGC death, and
RNFL thinning, in response to murine optic glioma.

Materials and methods
Mice
Nf1flox/mut;GFAP-Cre mice (Nf1+/− mice with somatic Nf1
loss in neuroglial progenitor cells) were generated and maintained on a C57BL/6 background (Bajenaru et al., 2003).
Analysis of mice was performed at 3 mo of age using independently generated cohorts. All animals were used in
accordance with protocols approved by the animal studies
committee at Washington University.
Pharmacological treatments
4-vinylcycohexene diepoxide (VCD; 160 mg/kg; Sigma-Aldrich) diluted in corn oil (vehicle) was administered by i.p. injection for 20 consecutive d. Minocycline
hydrochloride (50 mg/kg; Sigma-Aldrich) dissolved in
sterile PBS was administered by i.p. injection for 5 d/
week (2 wk), and controls received PBS injections. The
selective ERβ antagonist PHTPP (4 mg/kg body weight;
Sigma-Aldrich) was dissolved in corn oil and administered
i.p. for 5 d/week (6 wk to 3 mo of age). Controls received
i.p. corn oil injections.

unchanged after castration. (G) Optic nerve volumes (top; Sham, 0.085 ± 0.006 mm3; OVX, 0.049 ± 0.004 mm3; n = 5 mice/group) and %Ki67+ cells (middle;
Sham, 3.2 ± 0.64%; OVX, 0.96 ± 0.34%; n = 5 mice/group) were decreased after OVX. Axonal damage (pNF-H, bottom) was decreased after OVX of Nf1-OPG
females relative to sham controls. Data in A–G were analyzed using a nonparametric Student’s t test (Mann-Whitney). Similar results were obtained in a
second independent experiment containing six mice per group. Bars, 100 µm. *, P < 0.05; **, P < 0.01; ***, P < 0.001; n.s., not significant.
JEM Vol. 214, No. 1
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Estrogen acts through ERβ to activate optic nerve
microglia in female Nf1-OPG mice
Estrogen can function either through its canonical (ERα and
ERβ) receptors (Green et al., 1986; Kuiper et al., 1996) or
via G-protein–coupled receptors (GPR30; Revankar et al.,
2005). We first excluded GPR30 as a possible mediator using
a selective GRP30 antagonist, G-15 (Dennis et al., 2009),
and found that treatment of female Nf1-OPG mice did not
change RGC apoptosis (unpublished data). Next, we focused
on the ERα and ERβ receptors, which are both expressed
in the optic nerve. However, ERβ is exclusively expressed in
microglia (Wu et al., 2013), as confirmed herein using double-labeling immunohistochemistry (Fig. 4 A).
Two inflammatory cytokines (IL-1β and IL-6) implicated in neuronal apoptosis (Azevedo et al., 2013; Guadagno
et al., 2015) are known to be regulated by ERβ engagement
in brain microglia (Saijo et al., 2011). For this reason, we examined IL-1β (Fig. 4 B) and IL-6 (Fig. 4 C) levels, which
were both elevated in the optic nerves of female, but not male,
Nf1-OPG mice. To determine whether microglial activation, cytokine production, and subsequent neuronal damage
were driven by ERβ activation, female Nf1-OPG mice were
treated for 6 wk with 4-[2-phenyl-5,7-bis(trifluoromethyl)
pyrazolo[1,5-a]-pyrimidin-3-yl]phenol (PHTPP), a selective
ERβ antagonist (Compton et al., 2004). After treatment, there
was a 2.4-fold decrease in the percentage of Iba1+ cells, 20%
decrease in optic nerve volumes, and 7.5-fold decrease in proliferation (%Ki67+ cells), as well as reduced pNF-H staining
and IL-1β/IL-6 expression (Fig. 4 D). The observed positive
regulation of IL-1β in microglia by estradiol contrasts with
other studies demonstrating negative regulation (Saijo et
al., 2011; Zhao et al., 2016), which we postulate may reflect
different disease contexts (experimental allergic encephalomyelitis versus neoplasia) and/or divergent mechanisms of
estradiol signaling (GPR30 versus ERβ engagement).
Consistent with a critical role for microglia ERβ function in mediating neuronal cell death, ERβ inhibition decreased RGC apoptosis (%TUN
EL+ cells) to WT levels,
increased the percentage of RGC number to 81% of WT
levels, and increased the RNFL thickness from ∼44 to 100%
of WT levels in Nf1-OPG mice (Fig. 4 E). Although it is

not possible to completely separate the effects of ERβ activation on microglia-induced tumor growth from its effects
on neuronal injury, these findings support a model in which
microglia are critical drivers of glioma formation and maintenance in both male and female Nf1 mice, likely through
the actions of nonsexually dimorphic stromal factors (e.g.,
CCL5), whereas the tumor microenvironment created by
ERβ-mediated release of neurotoxins (e.g., IL-1β and other
inflammatory cytokines) facilitates the axonal injury, RGC
death, RNFL thinning, and visual impairment observed
in female Nf1-OPG mice.
In summary, these studies reveal critical roles for both
estrogen and microglia in the neuronal injury response to
optic glioma; however, the precise mechanism by which
microglia create a neurotoxic environment, independent of
tumor size, remains to be elucidated. Current studies are
under way to examine specific inflammatory mediators
(e.g., IL-1β and IL-6), as well as to define the transcriptional program of microglia in response to ERβ activation
in the context of murine Nf1-OPG. The finding that female susceptibility to axonal injury, retinal pathology, and
vision loss in the setting of optic glioma reflects estrogen
activation of microglia represents one of the first demonstrations of sexually dimorphic differences in human disease.
As the underlying molecular and cellular etiologies become
clearer, potential neuroprotective strategies for reversing visual decline might emerge.

Western blotting
Retinae were microdissected and tissues were sonicated in 1%
NP-40 buffer supplemented with protease and phosphatase
inhibitors. Protein concentrations were determined using a
BCA protein assay kit (Thermo Fisher Scientific), and Western blotting was performed as previously described using
SMI-32 (BioLegend; 1:500 dilution; Daginakatte and Gut22

mann, 2007) antibodies and developed using chemiluminescence detection on a ChemiDoc-It Imaging System (UVP).
Retinal flat-mount staining
Eyes were fixed with 4% paraformaldehyde for 1 h and washed
with PBS, and retinae were microdissected using 4 small incisions. Retinae were post-fixed in methanol and stored overEstrogen increases microglia-mediated retinal damage | Toonen et al.
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Figure 3. Microglia causes axonal damage and RGC death in female Nf1-OPG mice. (A) Optic nerves of female Nf1-OPG mice contained increased
%Iba1+ cells (Male, 5.8 ± 2.11%; Female, 12.96 ± 5.06%; n = 10 mice/group) and p-JNK+ cells (Male, 4.16 ± 3.2%; Female, 13.5 ± 4.7%; n = 8 mice/group).
(B) Immunostaining revealed increased Iba1+ cells in Nf1+/− females compared with WT controls (WT, 6.7 ± 1.1%; Nf1+/−, 9.9 ± 1.1%; n = 6 mice/group);
however, no differences were observed in males (WT, 6.9 ± 1.7%; Nf1+/−, 7.4 ± 1.3%). (C) The %Iba1+ cells (top; Sham, 6.21 ± 2.05%; Cast, 6.1 ± 2.26%; n =
8 mice/group) did not differ between castrated Nf1-OPG males and sham controls. In contrast, the %Iba1+ cells (bottom; Sham, 10.7 ± 4.84%; OVX, 5.83 ±
1.55%; n = 11 mice/group) were decreased after OVX in Nf1-OPG females compared with sham controls. Ramified microglia constitute 19.8% of the total
microglia in sham Nf1-OPG female mice and 53.6% of the total microglia after OVX, whereas amoeboid or activated microglia are constituted 70% of the
total microglia in sham Nf1-OPG optic nerves and 32% in OVX optic nerves (n = 6 mice/group). (D) Minocycline-treated female Nf1-OPG mice exhibited a
decreased %Iba1+ cells in the optic nerve (Control, 11.12 ± 1.71%; minocycline, 6.61 ± 2.3%; n = 8 mice/group) and axonal damage (pNF-H immunostaining).
(E) After minocycline treatment, there was a reduction in the %TUNEL+ cells (Control, 14.75 ± 1.1; minocycline, 3.75 ± 1.82; n = 6 mice/group), an increase in
the %Brn3a+ cells (Control, 39.79 ± 1.69%; minocycline, 70.42 ± 2.66%; n = 6 mice/group), and increased the RNFL thickness (SMI-32 staining; Control, 4.51
± 1.1 µm; minocycline, 9.2 ± 1.9 µm; n = 8 mice/group). Data in A–E were analyzed using a nonparametric Student’s t test (Mann-Whitney). Similar results
were obtained in a second independent experiment containing five mice per group. Bars, 100 µm. *, P < 0.05; **, P < 0.01; ***, P < 0.001. n.s., not significant.
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Figure 4. Estrogen acts through ERβ to activate optic nerve microglia in female Nf1-OPG mice. (A) Immunostaining for Iba1+, ERα+ double-labeled
cells in the optic nerve (bottom, arrows). Immunostaining was performed for Il-1β (B) and Il-6 (C) in the optic nerves of FF male and female mice, as well
as in Nf1-OPG male and female mice. (D) Optic nerves volumes (Control, 0.089 ± 0.02 mm3; PHTPP, 0.071 ± 0.01 mm3; n = 7 mice/group) and %Ki67+ cells
(Control, 4.75 ± 2.2%; PHTPP, 0.64 ± 0.59%; n = 6 mice/group) were decreased after PHTPP treatment (top). Microglia numbers (%Iba1+ cells, Control, 12.33
± 5.9; PHTPP, 5.44 ± 1.3, n = 8 mice/group), axonal injury (pNF-H), and IL-1β/IL-6 levels were decreased after treatment with PHTPP. (E) PHTPP treatment
reduced the %TUNEL+ cells (Control, 10.7 ± 0.78%; PHTPP, 1.95 ± 0.56%; n = 6 mice/group), increased the %Brn3a+ cells (Control, 49.58 ± 2.69%; PHT
PP, 81.7 ± 4.9%; n = 6 mice/group), and increased the RNFL thickness (SMI-32 staining; Control, 4.5 ± 0.4 µm; PHTPP, 10.5 ± 0.5 µm; n = 6 mice/group).
Data in D and E were analyzed using a nonparametric Student’s t test (Mann-Whitney). Similar results were obtained in a second independent experiment
containing five mice per group. Bars, 100 µm. *, P < 0.05; **, P < 0.01; ***, P < 0.001. n.s., not significant.
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night before incubation with SMI-32 antibody overnight
(1:250) and immunofluorescent microscope imaging.

and Testosterone (Enzo Life Sciences) ELISA kits as per the
manufacturer’s protocol.

Castration and OVX
After anesthesia, 6-wk-old male mice were castrated by vas
deferens cauterization using sterile surgical instruments in
the Mouse Genetics Core at Washington University. Similarly, 6-wk-old female mice were surgically OVX and their
fallopian tubes were ligated. Afterward, the skin was sutured
and topical analgesics lidocaine ointment or bupivacaine
were applied. Sham controls underwent identical procedures minus the gonadectomy.

Statistical analysis
Statistical analysis was performed using Prism 5.0 software
(GraphPad). Analyses involving only two groups were performed using nonparametric Student’s t test (Mann-Whitney) and four groups were compared using a nonparametric
one-way ANOVA (Kruskal-Wallis test) using Dunn’s multiple
comparison posttest. Statistical significance predetermined to
be P < 0.05 for all statistical tests.

Optic nerve measurements
Microdissected optic nerves were fixed in 4% paraformaldehyde overnight and then photographed, and diameters
were measured beginning at the chiasm (and subsequently
∼150, ∼300, and ∼450 µm anterior to the chiasm) to
generate optic nerve volumes as previously reported
(Hegedus et al., 2008).
Retinal analyses
RNFL measurements were performed using ImageJ (National Institutes of Health) software on sections through
the plain including pupil and optic nerves. Images were
taken at 20× fields from 0 to 300 µm proximal to the
optic nerve head. Repeated measurements of stained axons
(SMI-32+staining) were recorded and averaged for each area
corresponding to each genotype.
Serum estradiol and testosterone assay
Serum was separated from whole blood after centrifugation and analyzed using 17β-Estradiol (Enzo Life Sciences)
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